United States Pharmaceuticals

NextCure Inc (NXTC)

Track

Over the past 90 days, NextCure Inc. recorded four insider transactions, all consisting of open-market purchases by ADAR1 Capital Management, LLC. These transactions totaled approximately $87,713 in net buying. This activity occurs amid a 46.4% decline in the stock price over the same period, ahead of the company's next scheduled earnings report in August 2026.
Ticker: NXTC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NextCure Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 29 Jul 2026
Value US$3,950,736.27 | Price 263.85 | Shares 43,579 (+22.6%)
Buy 29 Jul 2026
Value US$2,518,463.58 | Price 129.56 | Shares 91,131 (+6.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-29 B Purchase
3.9
ADAR1 Capital Management, LLC
Large shareholder
43,579 +22.6%
263.85
US$3,950,736 		43,579 +22.6% 263.85 US$3,950,736
2026-07-29 2026-07-29 B Purchase
3.9
ADAR1 Capital Management, LLC
Large shareholder
91,131 +6.1%
129.56
US$2,518,464 		91,131 +6.1% 129.56 US$2,518,464
2026-07-29 2026-07-28 B Purchase
3.9
ADAR1 Capital Management, LLC
Large shareholder
86,542 -46.3%
19.61
US$1,088,488 		86,542 -46.3% 19.61 US$1,088,488
2026-07-29 2026-07-27 B Purchase
3.9
ADAR1 Capital Management, LLC
Large shareholder
1,000 +2.1%
5.00
US$100,000 		1,000 +2.1% 5.00 US$100,000
2019-11-19 2019-11-15 B Purchase Sofinnova Venture Partners IX, L.P. Large shareholder
150,000 +5.9%
36.75
US$5,512,500 		150,000 +5.9% 36.75 US$5,512,500
2019-05-15 2019-05-13 B Purchase
3.6
Sofinnova Venture Partners IX, L.P.
Large shareholder
400,000 +18.9%
15.00
US$6,000,000 		400,000 +18.9% 15.00 US$6,000,000
2019-05-13 2019-05-13 B Purchase
CANAAN X L.P.
Large shareholder
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
3.3
Xu Stella
125,000 +12.8%
15.00
US$1,875,000 		125,000 +12.8% 15.00 US$1,875,000
2019-05-13 2019-05-13 B Purchase
2.5
Khuong Chau Quang
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
2019-05-13 2019-05-13 B Purchase
3.8
SHANNON TIMOTHY M
Non-Executive Director
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
Explore more

More insider trading research around NextCure Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America